Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB) Implantation in Non-Infected Hypotrophic Non-Union Fractures

Next Previous
Trial Profile

A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB) Implantation in Non-Infected Hypotrophic Non-Union Fractures

Status: Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 27 Dec 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 03 Jul 2019 Status changed from active, no longer recruiting to discontinued.
  • 24 Jul 2018 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
  • 19 Dec 2017 Status of trial is kept as active not recruiting as per investigators reply mentioning that competent authorities have been notified of the termination of the PREOB NU3 trial. As post treatment long-term safety follow-up is on-going, CT.gov status is active not recruiting. Patient still have to pass visit for safety purpose (last visit planned around April 2018). The study is effectively terminated for efficacy purpose since the last treated patient had the last efficacy visit.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top